Palabras claves: Biomarker, Blood, covid-19, Laboratory safety, RNA, SARS-COV-2, Viraemia, Viral load
Autores: Andersson M.I., Arancibia-Cárcamo C.V., Auckland K., Baillie J.K., Barnes E., Beneke T., Bibi S., Brooks T.J.G., Carroll M.W., Crook D.W., Dingle K., Dold C., Downs L.O., Dunn L., Eyre D.W., Harvala H., Hoosdally S., Ijaz S., James T., James W.S., Javier Gilbert Jaramillo, Jeffery K., Justice A., Klenerman P., Knight J.C., Knight M.L., Liu X., Lumley S.F., Matthews P.C., McNaughton A.L., Mentzer A.J., Mongkolsapaya J., Oakley S., Oliveira M.S., Peto T., Ploeg R.J., Ratcliff J., Robbins M.J., Roberts D.J., Rudkin J., Russell R.A., Screaton G.R., Semple M.G., Simmonds P., Skelly D.T., Stoesser N., Turtle L., Wareing S., Zambon M.
